SLC7A5 and central nervous system cancer: The results are in accordance with a previous study using [123I]IMT SPECT under fasting conditions and a week later during intravenous infusion of a mixture of naturally-occurring LAT1-relevant AMAs in different brain tumours showing a reduction of uptake relative to blood of 46% in normal brain and of 53% in five glioma patients [15].